Katerina Mackova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Katerina Mackova has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- Radek Janca
Department of Circuit Theory, Faculty of Electrical Engineering, Czech Technical University in Prague, Prague, Czech Republic
5 shared publications Alena Jahodova
Department of Pediatric Neurology Second Faculty of Medicine, Charles University and Motol University Hospital, full member of the European Reference Network EpiCARE Prague Czech Republic
3 shared publications- Matyas Ebel
Department of Paediatric Neurology, Second Faculty of Medicine, Charles University, Motol and Homolka University Hospital, a full member of European Reference Network EpiCARE, V Uvalu 84/1, Prague 5, 150 06, Czech Republic
3 shared publications - Adam Kalina
Department of Neurology, Second Faculty of Medicine, Charles University, Motol and Homolka University Hospital, a full member of European Reference Network EpiCARE, V Uvalu 84/1, Prague 5, 150 06, Czech Republic
2 shared publications - Alice Maulisova
Department of Clinical Psychology Motol University Hospital, Full Member of the ERN EpiCARE and Epilepsy Research Centre Prague ‐ EpiReC Consortium Prague Czech Republic
2 shared publications - Anezka Belohlavkova
Department of Pediatric Neurology, Motol Epilepsy Center, Second Faculty of Medicine Charles University and Motol University Hospital, Full Member of the ERN EpiCARE and Epilepsy Research Centre Prague ‐ EpiReC Consortium Prague Czech Republic
2 shared publications
Latest Publications
- Open Access
Quantification of patient motion in FDG-PET/CT brain imaging
Objectives: FDG-PET is an important imaging tool in evaluation of neurological disorders, including drug-resistant epilepsy. Head motion can degrade PET image quality; however, the extent in routine examinations remains insufficiently characterized. This retrospective study aimed to quantify the magnitude and pattern of head motion in brain FDG-PET/CT and establish displacement-based scores for describing motion severity. Materials & Methods: The analysis included 140 patients with focal drug-resistant epilepsy undergoing brain FDG-PET/CT, with 27 examined under general anesthesia as a reference group. PET acquisition comprised five consecutive 2-min frames. Head motion was quantified by rigid PET-to-PET registration and expressed as maximal displacement. Two experienced readers independently graded motion on a four-point ordinal scale. Ordinal logistic regression with repeated 10-fold cross-validation was used to derive displacement thresholds corresponding to visual motion scores. Results: Patients without anesthesia demonstrated greater maximal displacement than the reference group (median, 2.6 vs. 0.7 mm; p < 0.001). Displacement increased throughout acquisition, peaking in the final frame in 85.7% of examinations. Motion predominantly involved inferior–superior translation and rotation around left–right axis, corresponding to head flexion–extension. Maximal displacement was strongly associated with visual motion grades (Kendall’s τ=0.68–0.70; p < 0.001). Derived thresholds classified displacement >3.25 mm as moderate and >6.4 mm as severe motion. In total, 40.7% of patients without anesthesia demonstrated moderate or severe motion, with severe motion in 12.4%. Conclusion: Clinically relevant head motion was frequent in brain FDG-PET/CT despite head fixation, predominantly characterized by flexion–extension. Registration-based displacement provided an objective measure closely associated with expert visual assessment. Key points: This study investigated the frequency of clinically relevant head motion in brain FDG-PET/CT and whether image-based displacement can provide an objective measure of motion severity. Clinically relevant head motion occurred in approximately 40% of brain FDG-PET/CTs, with severe motion in 12.4% of examinations and flexion–extension being the predominant pattern. Direct quantitative assessment of head motion from dynamic PET data may improve recognition of clinically relevant motion and support objective decisions on motion correction and repeat acquisition, potentially improving the reliability of brain FDG-PET/CT interpretation.
Open AccessQuantification of patient motion in FDG-PET/CT brain imaging
Objectives: FDG-PET is an important imaging tool in evaluation of neurological disorders, including drug-resistant epilepsy. Head motion can degrade PET image quality; however, the extent in routine examinations remains insufficiently characterized. This retrospective study aimed to quantify the magnitude and pattern of head motion in brain FDG-PET/CT and establish displacement-based scores for describing motion severity. Materials & Methods: The analysis included 140 patients with focal drug-resistant epilepsy undergoing brain FDG-PET/CT, with 27 examined under general anesthesia as a reference group. PET acquisition comprised five consecutive 2-min frames. Head motion was quantified by rigid PET-to-PET registration and expressed as maximal displacement. Two experienced readers independently graded motion on a four-point ordinal scale. Ordinal logistic regression with repeated 10-fold cross-validation was used to derive displacement thresholds corresponding to visual motion scores. Results: Patients without anesthesia demonstrated greater maximal displacement than the reference group (median, 2.6 vs. 0.7 mm; p < 0.001). Displacement increased throughout acquisition, peaking in the final frame in 85.7% of examinations. Motion predominantly involved inferior–superior translation and rotation around left–right axis, corresponding to head flexion–extension. Maximal displacement was strongly associated with visual motion grades (Kendall’s τ=0.68–0.70; p < 0.001). Derived thresholds classified displacement >3.25 mm as moderate and >6.4 mm as severe motion. In total, 40.7% of patients without anesthesia demonstrated moderate or severe motion, with severe motion in 12.4%. Conclusion: Clinically relevant head motion was frequent in brain FDG-PET/CT despite head fixation, predominantly characterized by flexion–extension. Registration-based displacement provided an objective measure closely associated with expert visual assessment. Key points: This study investigated the frequency of clinically relevant head motion in brain FDG-PET/CT and whether image-based displacement can provide an objective measure of motion severity. Clinically relevant head motion occurred in approximately 40% of brain FDG-PET/CTs, with severe motion in 12.4% of examinations and flexion–extension being the predominant pattern. Direct quantitative assessment of head motion from dynamic PET data may improve recognition of clinically relevant motion and support objective decisions on motion correction and repeat acquisition, potentially improving the reliability of brain FDG-PET/CT interpretation.
- 28 May 2025
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 1-6
Effective Image Resolution for Partial Volume Correction in FDG-PET Brain Imaging: A Proof of Concept
Neuroimaging of subtle hypometabolic epileptogenic lesions using 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) is challenging due to its limited spatial resolution, which causes partial volume effects (PVE), leading to image blurring and underestimation of radiotracer activity. Partial volume correction (PVC) post-processing compensates for the blurring, but relies on accurate knowledge of the point spread function (PSF), which must be provided as an input parameter. However, no guidelines exist for determining an appropriate PSF value, which varies with scanner type, reconstruction algorithm, and scanned object properties. We conducted phantom measurements on Siemens Biograph mCT 40 and Vision 600 scanners using a clinical reconstruction protocol to compare two PSF estimation methods: one based on capillary phantom (following NEMA) and another using effective image resolution (EIR) of Hoffman phantom images (following EARL guideline). The impact of the PSF estimation method on PVC performance was assessed using image quality metrics: gray matter recovery coefficient (GMRC), gray matter edge recovery coefficient (GMERC), and gray matter coefficient of variation (GMCOV). PVC with both PSF estimation methods improved image quality compared to the original images. However, PVC with input PSF estimated by EIR showed better performance than PVC with capillary-based estimate: GMRC was 92-94% vs. 85-86%, GMERC was 85-90% vs. 78-79%, and lower GMCOV: 18-22% vs. 20-23%. These findings suggest that the estimation of input PSF by EIR could be a more reliable and practical approach for PVC in clinical FDG-PET brain imaging, especially since it is already used in the EARL F/C Brain PET/CT Accreditation.
- 28 May 2025
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 1-6
Effective Image Resolution for Partial Volume Correction in FDG-PET Brain Imaging: A Proof of Concept
Neuroimaging of subtle hypometabolic epileptogenic lesions using 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) is challenging due to its limited spatial resolution, which causes partial volume effects (PVE), leading to image blurring and underestimation of radiotracer activity. Partial volume correction (PVC) post-processing compensates for the blurring, but relies on accurate knowledge of the point spread function (PSF), which must be provided as an input parameter. However, no guidelines exist for determining an appropriate PSF value, which varies with scanner type, reconstruction algorithm, and scanned object properties. We conducted phantom measurements on Siemens Biograph mCT 40 and Vision 600 scanners using a clinical reconstruction protocol to compare two PSF estimation methods: one based on capillary phantom (following NEMA) and another using effective image resolution (EIR) of Hoffman phantom images (following EARL guideline). The impact of the PSF estimation method on PVC performance was assessed using image quality metrics: gray matter recovery coefficient (GMRC), gray matter edge recovery coefficient (GMERC), and gray matter coefficient of variation (GMCOV). PVC with both PSF estimation methods improved image quality compared to the original images. However, PVC with input PSF estimated by EIR showed better performance than PVC with capillary-based estimate: GMRC was 92-94% vs. 85-86%, GMERC was 85-90% vs. 78-79%, and lower GMCOV: 18-22% vs. 20-23%. These findings suggest that the estimation of input PSF by EIR could be a more reliable and practical approach for PVC in clinical FDG-PET brain imaging, especially since it is already used in the EARL F/C Brain PET/CT Accreditation.
- Open Access
A new perspective on drug‐resistant epilepsy in children with focal cortical dysplasia type 1: From challenge to favorable outcome
Objective: We comprehensively characterized a large pediatric cohort with focal cortical dysplasia (FCD) type 1 to expand the phenotypic spectrum and to identify predictors of postsurgical outcomes. Methods: We included pediatric patients with histopathological diagnosis of isolated FCD type 1 and at least 1 year of postsurgical follow‐up. We systematically reanalyzed clinical, electrophysiological, and radiological features. The results of this reanalysis served as independent variables for subsequent statistical analyses of outcome predictors. Results: All children ( N = 31) had drug‐resistant epilepsy with varying impacts on neurodevelopment and cognition (presurgical intelligence quotient [IQ]/developmental quotient scores = 32–106). Low presurgical IQ was associated with abnormal slow background electroencephalographic (EEG) activity and disrupted sleep architecture. Scalp EEG showed predominantly multiregional and often bilateral epileptiform activity. Advanced epilepsy magnetic resonance imaging (MRI) protocols identified FCD‐specific features in 74.2% of patients (23/31), 17 of whom were initially evaluated as MRI‐negative. In six of eight MRI‐negative cases, fluorodeoxyglucose–positron emission tomography (PET) and subtraction ictal single photon emission computed tomography coregistered to MRI helped localize the dysplastic cortex. Sixteen patients (51.6%) underwent invasive EEG. By the last follow‐up (median = 5 years, interquartile range = 3.3–9 years), seizure freedom was achieved in 71% of patients (22/31), including seven of eight MRI‐negative patients. Antiseizure medications were reduced in 21 patients, with complete withdrawal in six. Seizure outcome was predicted by a combination of the following descriptors: age at epilepsy onset, epilepsy duration, long‐term invasive EEG, and specific MRI and PET findings. Significance: This study highlights the broad phenotypic spectrum of FCD type 1, which spans far beyond the narrow descriptions of previous studies. The applied multilayered presurgical approach helped localize the epileptogenic zone in many previously nonlesional cases, resulting in improved postsurgical seizure outcomes, which are more favorable than previously reported for FCD type 1 patients.
Open AccessA new perspective on drug‐resistant epilepsy in children with focal cortical dysplasia type 1: From challenge to favorable outcome
Objective: We comprehensively characterized a large pediatric cohort with focal cortical dysplasia (FCD) type 1 to expand the phenotypic spectrum and to identify predictors of postsurgical outcomes. Methods: We included pediatric patients with histopathological diagnosis of isolated FCD type 1 and at least 1 year of postsurgical follow‐up. We systematically reanalyzed clinical, electrophysiological, and radiological features. The results of this reanalysis served as independent variables for subsequent statistical analyses of outcome predictors. Results: All children ( N = 31) had drug‐resistant epilepsy with varying impacts on neurodevelopment and cognition (presurgical intelligence quotient [IQ]/developmental quotient scores = 32–106). Low presurgical IQ was associated with abnormal slow background electroencephalographic (EEG) activity and disrupted sleep architecture. Scalp EEG showed predominantly multiregional and often bilateral epileptiform activity. Advanced epilepsy magnetic resonance imaging (MRI) protocols identified FCD‐specific features in 74.2% of patients (23/31), 17 of whom were initially evaluated as MRI‐negative. In six of eight MRI‐negative cases, fluorodeoxyglucose–positron emission tomography (PET) and subtraction ictal single photon emission computed tomography coregistered to MRI helped localize the dysplastic cortex. Sixteen patients (51.6%) underwent invasive EEG. By the last follow‐up (median = 5 years, interquartile range = 3.3–9 years), seizure freedom was achieved in 71% of patients (22/31), including seven of eight MRI‐negative patients. Antiseizure medications were reduced in 21 patients, with complete withdrawal in six. Seizure outcome was predicted by a combination of the following descriptors: age at epilepsy onset, epilepsy duration, long‐term invasive EEG, and specific MRI and PET findings. Significance: This study highlights the broad phenotypic spectrum of FCD type 1, which spans far beyond the narrow descriptions of previous studies. The applied multilayered presurgical approach helped localize the epileptogenic zone in many previously nonlesional cases, resulting in improved postsurgical seizure outcomes, which are more favorable than previously reported for FCD type 1 patients.
- Open Access
Multi-layered Diagnostic Protocol Improves Postsurgical Outcomes in Children with Drug-resistant Epilepsy And Focal Cortical Dysplasia Type 1
Objectives: We comprehensively characterised a large paediatric cohort with histologically confirmed focal cortical dysplasia (FCD) type 1 to demonstrate the role of advanced multimodal pre-surgical evaluation and identify predictors of postsurgical outcomes. Methods: This study comprised a systematic re-analysis of clinical, electrophysiological, and radiological features. The results of this re-analysis served as independent variables for subsequent statistical analyses of outcome predictors. Results: All children (N = 31) had drug-resistant epilepsy with varying impacts on neurodevelopment and cognition (presurgical intelligence quotient (IQ)/developmental quotient scores: 32–106). Low presurgical IQ was associated with abnormal slow background electroencephalogram (EEG) activity and disrupted sleep architecture. Scalp EEG showed predominantly multiregional and often bilateral epileptiform activity. Advanced epilepsy magnetic resonance imaging (MRI) protocols identified FCD-specific features in 74.2% of patients (23/31), 17 of whom were initially evaluated as MRI-negative. In six out of eight MRI-negative cases, fluorodeoxyglucose positron emission tomography (FDG-PET) and subtraction ictal single-photon emission computed tomography co-registered to MRI (SISCOM) helped localise the dysplastic cortex. Sixteen patients (51.6%) underwent stereoelectroencephalography (SEEG). Twenty-eight underwent resective surgery, and three underwent hemispheral disconnection. Seizure freedom was achieved in 71.0% of patients (22/31) by the last follow-up, including seven of the eight MRI-negative patients. Anti-seizure medications (ASMs) were reduced in 21 patients, with complete withdrawal in 5 individuals. Seizure outcome was predicted by a combination of the following descriptors: age at epilepsy onset, epilepsy duration, long-term invasive EEG, and specific MRI, and PET findings. Significance: This study highlights the broad phenotypic spectrum of FCD type 1, which spans far beyond the narrow descriptions of previous studies. Combining advanced MRI protocols with additional neuroimaging techniques helped localise the epileptogenic zone in many previously non-lesional cases. Complex multimodal presurgical approaches (including SEEG) could enhance postsurgical outcomes in these complex patients. Key points: The phenotypic spectrum of paediatric patients with FCD type 1 spans beyond the narrow description of previous studies MRI-negative patients benefit from enhanced precision in localising the epileptogenic zone, facilitated by FDG-PET, SISCOM, and SEEG A complex multimodal presurgical approach could enhance postoperative seizure outcomes in patients with FCD type 1 Paediatric patients with suspected FCD type 1 should be referred to epilepsy surgery centres as soon as possible
Open AccessMulti-layered Diagnostic Protocol Improves Postsurgical Outcomes in Children with Drug-resistant Epilepsy And Focal Cortical Dysplasia Type 1
Objectives: We comprehensively characterised a large paediatric cohort with histologically confirmed focal cortical dysplasia (FCD) type 1 to demonstrate the role of advanced multimodal pre-surgical evaluation and identify predictors of postsurgical outcomes. Methods: This study comprised a systematic re-analysis of clinical, electrophysiological, and radiological features. The results of this re-analysis served as independent variables for subsequent statistical analyses of outcome predictors. Results: All children (N = 31) had drug-resistant epilepsy with varying impacts on neurodevelopment and cognition (presurgical intelligence quotient (IQ)/developmental quotient scores: 32–106). Low presurgical IQ was associated with abnormal slow background electroencephalogram (EEG) activity and disrupted sleep architecture. Scalp EEG showed predominantly multiregional and often bilateral epileptiform activity. Advanced epilepsy magnetic resonance imaging (MRI) protocols identified FCD-specific features in 74.2% of patients (23/31), 17 of whom were initially evaluated as MRI-negative. In six out of eight MRI-negative cases, fluorodeoxyglucose positron emission tomography (FDG-PET) and subtraction ictal single-photon emission computed tomography co-registered to MRI (SISCOM) helped localise the dysplastic cortex. Sixteen patients (51.6%) underwent stereoelectroencephalography (SEEG). Twenty-eight underwent resective surgery, and three underwent hemispheral disconnection. Seizure freedom was achieved in 71.0% of patients (22/31) by the last follow-up, including seven of the eight MRI-negative patients. Anti-seizure medications (ASMs) were reduced in 21 patients, with complete withdrawal in 5 individuals. Seizure outcome was predicted by a combination of the following descriptors: age at epilepsy onset, epilepsy duration, long-term invasive EEG, and specific MRI, and PET findings. Significance: This study highlights the broad phenotypic spectrum of FCD type 1, which spans far beyond the narrow descriptions of previous studies. Combining advanced MRI protocols with additional neuroimaging techniques helped localise the epileptogenic zone in many previously non-lesional cases. Complex multimodal presurgical approaches (including SEEG) could enhance postsurgical outcomes in these complex patients. Key points: The phenotypic spectrum of paediatric patients with FCD type 1 spans beyond the narrow description of previous studies MRI-negative patients benefit from enhanced precision in localising the epileptogenic zone, facilitated by FDG-PET, SISCOM, and SEEG A complex multimodal presurgical approach could enhance postoperative seizure outcomes in patients with FCD type 1 Paediatric patients with suspected FCD type 1 should be referred to epilepsy surgery centres as soon as possible
- 17 April 2023
- Published by Elsevier in Clinical Neurophysiology
- Vol. 151, 10-17
Distinct patterns of interictal intracranial EEG in focal cortical dysplasia type I and II
- 17 April 2023
- Published by Elsevier in Clinical Neurophysiology
- Vol. 151, 10-17
Distinct patterns of interictal intracranial EEG in focal cortical dysplasia type I and II